Delivery Order SPE2DB24D1205-SPE2DB24FCTPA

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,980.34 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565481765 EPINEPHRINE 1 MG/10 ML LUERJET 10ML, with an ultimate completion date of August 19, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,580,138 units of EPINEPHRINE 1 MG/10 ML LUERJET 10ML. The $1,530.00 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order is issued under Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564202717 EPINEPHRINE 1 MG/10 ML LUERJET 10ML. The contract has a ceiling value of $1,192.95 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.00, is for the delivery of EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. This is a Firm Fixed Price Delivery Order contract with a period of performance through January 13, 2025. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. The contract has a ceiling value of $1,511.64 and runs through November 18, 2024. This is a delivery order contract with firm-fixed pricing. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 1 mg/10 ml Luerjet 10 ml. The $4,972.73 firm-fixed-price contract has an ultimate completion date of April 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,537.56 firm fixed-price delivery order is for the provision of EPINEPHRINE 1 MG/10 ML LUERJET 10ML, with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,303.20 firm fixed-price contract is for the delivery of EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a critical medical product. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $1,722.76 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 4564235769 EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,329.58, is for the delivery of 4566824101 - Epinephrine 1 mg/10 ml Luerjet 10ml. It is a firm fixed-price contract with a completion date of January 3, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTPA
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,719.03 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565402141 EPINEPHRINE 1 MG/10 ML LUERJET 10ML. This contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a broad range of medical commodities and prescription drugs to support federal healthcare programs and facilities.

Generated 11/8/24, 9:11 AM